| RS140251121 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140251789 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS140254310 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS140254470 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Inborn genetic diseases |
| RS140254478 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS140254589 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS140254802 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, IL12RB1-related disorder |
| RS140255077 |
NEK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 9, Nephronophthisis 9 |
| RS140255091 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS140255233 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1402556079 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS140256288 |
KCNV2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy with supernormal rod response, Retinal dystrophy |
| RS140256463 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1402571360 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1402571742 |
CFAP418
|
Health Risk |
Pathogenic |
— |
| RS1402574017 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS140257538 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Macular dystrophy |
| RS140257722 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1402584432 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS140259310 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS140259346 |
NR0B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital adrenal hypoplasia |
| RS140260219 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 39 |
| RS1402604190 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1402606705 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS140261054 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoglycanopathy, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS140261309 |
PDGFRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Acroosteolysis-keloid-like lesions-premature aging syndrome, Infantile myofibromatosis |
| RS1402616233 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS1402621591 |
CLDN1
|
Health Risk |
Likely pathogenic |
Neonatal ichthyosis-sclerosing cholangitis syndrome, Neonatal ichthyosis-sclerosing cholangitis syndrome |
| RS140262282 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS140262395 |
ECHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140262591 |
ATXN2
|
Health Risk |
Conflicting classifications of pathogenicity |
ATXN2-related disorder, ATXN2-related disorder |
| RS140262864 |
AQP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes insipidus, nephrogenic |
| RS1402634815 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS140263617 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS140263823 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS1402642604 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1402646371 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS140264933 |
BMPER
|
Health Risk |
Conflicting classifications of pathogenicity |
Diaphanospondylodysostosis, Diaphanospondylodysostosis |
| RS140265039 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1402652492 |
MYO5B
|
Health Risk |
Pathogenic |
— |
| RS1402657239 |
BSCL2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1402669959 |
CSPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS140267000 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1402670923 |
UNC13D
|
Health Risk |
Pathogenic |
— |
| RS1402672053 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1402672430 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS140267699 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS140268343 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome, Lethal multiple pterygium syndrome |
| RS140268486 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachyolmia-amelogenesis imperfecta syndrome, Geleophysic dysplasia 3 |
| RS140269225 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, MTOR-related disorder |
| RS140269316 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS1402701697 |
LAMC3
|
Health Risk |
Likely pathogenic |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS140270787 |
ATXN7
|
Health Risk |
Conflicting classifications of pathogenicity |
ATXN7-related disorder, ATXN7-related disorder |
| RS140271107 |
ACTN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS140271757 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140272085 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, DSD incomplete virilization |
| RS1402734026 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS140274454 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1402747036 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS1402755105 |
TGFBR2
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 2 |
| RS1402759053 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Osteogenesis imperfecta type I |
| RS1402761530 |
DLD
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS140276399 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Connective tissue disorder |
| RS1402767794 |
UPF3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Syndromic X-linked intellectual disability 14 |
| RS140277551 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1402775763 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS140277700 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS140279158 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1402802838 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS1402804629 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS140281678 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS1402819968 |
SMAD2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1402823262 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard Soulier syndrome, Bernard Soulier syndrome |
| RS1402841866 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS140284566 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Inborn genetic diseases |
| RS1402847477 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1402847914 |
MPL
|
Health Risk |
Pathogenic |
Essential thrombocythemia, Congenital amegakaryocytic thrombocytopenia |
| RS1402853810 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS140285782 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Van Maldergem syndrome 2, Hennekam lymphangiectasia-lymphedema syndrome 2 |
| RS140286718 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS140286824 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Achromatopsia |
| RS140287192 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS1402872886 |
KDM5B
|
Health Risk |
Pathogenic |
— |
| RS140287375 |
SPATA7
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 3, SPATA7-related disorder |
| RS140287760 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 |
| RS1402879259 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS140288103 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Episodic pain syndrome |
| RS140288388 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS140288481 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 1, Adams-Oliver syndrome 5 |
| RS1402885350 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1402891925 |
TECRL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1402893508 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Retinal dystrophy |
| RS1402893994 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 11 |
| RS1402894646 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS140289517 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS140290722 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS140291094 |
STAC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bailey-Bloch congenital myopathy, STAC3-related disorder |
| RS1402918571 |
MYO6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140291959 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS140292751 |
IARS1
|
Health Risk |
Pathogenic |
— |